Publication:
Renal Amyloidosis in Children

dc.contributor.authorBilginer, Yelda
dc.contributor.authorAkpolat, Tekin
dc.contributor.authorOzen, Seza
dc.date.accessioned2020-06-21T14:39:50Z
dc.date.available2020-06-21T14:39:50Z
dc.date.issued2011
dc.departmentOMÜen_US
dc.department-temp[Bilginer, Yelda -- Ozen, Seza] Hacettepe Univ, Fac Med, Pediat Nephrol & Rheumatol Unit, TR-06100 Ankara, Turkey -- [Akpolat, Tekin] Ondokuz Mayis Univ, Sch Med, Dept Nephrol, Samsun, Turkey --en_US
dc.description.abstractRenal amyloidosis is a detrimental disease caused by the deposition of amyloid fibrils. A child with renal amyloidosis may present with proteinuria or nephrotic syndrome. Chronic renal failure may follow. Amyloid fibrils may deposit in other organs as well. The diagnosis is through the typical appearance on histopathology. Although chronic infections and chronic inflammatory diseases used to be the causes of secondary amyloidosis in children, the most frequent cause is now autoinflammatory diseases. Among this group of diseases, the most frequent one throughout the world is familial Mediterranean fever (FMF). FMF is typically characterized by attacks of clinical inflammation in the form of fever and serositis and high acute-phase reactants. Persisting inflammation in inadequately treated disease is associated with the development of secondary amyloidosis. The main treatment is colchicine. A number of other monogenic autoinflammatory diseases have also been identified. Among them cryopyrin-associated periodic syndrome (CAPS) is outstanding with its clinical features and the predilection to develop secondary amyloidosis in untreated cases. The treatment of secondary amyloidosis mainly depends on the treatment of the disease. However, a number of new treatments for amyloid per se are in the pipeline.en_US
dc.identifier.doi10.1007/s00467-011-1797-x
dc.identifier.endpage1227en_US
dc.identifier.issn0931-041X
dc.identifier.issn1432-198X
dc.identifier.issue8en_US
dc.identifier.pmid21360109
dc.identifier.startpage1215en_US
dc.identifier.urihttps://doi.org/10.1007/s00467-011-1797-x
dc.identifier.urihttps://hdl.handle.net/20.500.12712/17106
dc.identifier.volume26en_US
dc.identifier.wosWOS:000291984200004
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.journalPediatric Nephrologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectRenal Amyloidosisen_US
dc.subjectChildrenen_US
dc.subjectAutoinflammatory Diseasesen_US
dc.titleRenal Amyloidosis in Childrenen_US
dc.typeReviewen_US
dspace.entity.typePublication

Files